{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T02:10:41Z","timestamp":1743041441239,"version":"3.40.3"},"publisher-location":"Cham","reference-count":53,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783031694905"},{"type":"electronic","value":"9783031694912"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-69491-2_3","type":"book-chapter","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T18:15:53Z","timestamp":1732040153000},"page":"67-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Public\u2013Private Partnerships for Neuropsychiatric Drug Development: A Perspective"],"prefix":"10.1007","author":[{"given":"William Z.","family":"Potter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"3_CR1","unstructured":"ADNI. Alzheimer\u2019s disease neuroimaging initiative [Internet]. 2023a. Available from: https:\/\/adni.loni.usc.edu\/."},{"key":"3_CR2","unstructured":"ADNI. History and Organization of the Alzheimer\u2019s disease neuroimaging initiative [Internet]. 2023b. Available from: https:\/\/adni.loni.usc.edu\/about\/."},{"key":"3_CR3","unstructured":"ADNI. Access to data and biological samples [Internet]. Internet; 2023c. Available from: https:\/\/adni.loni.usc.edu\/data-samples\/access-data\/."},{"key":"3_CR4","unstructured":"ADNI. Funding of ADNI [Internet]. 2023d. Available from: https:\/\/adni.loni.usc.edu\/about\/#fund-container."},{"key":"3_CR5","unstructured":"ADNI. Integration of AIBL data [Internet]. 2023e. Available from: https:\/\/adni.loni.usc.edu\/category\/aibl-study-data\/."},{"key":"3_CR6","unstructured":"AIBL. Australian Imaging Biomarkers and Lifetime Flagship Study of Aging [Internet]. 2023. Available from: https:\/\/aibl.csiro.au\/adni\/index.html."},{"issue":"1","key":"3_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/17460441.2014.867944","volume":"9","author":"LS Brady","year":"2014","unstructured":"Brady LS, Potter WZ. Public-private partnerships to revitalize psychiatric drug discovery. Expert Opin Drug Discov. 2014;9(1):1\u20138.","journal-title":"Expert Opin Drug Discov"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.dcn.2018.03.001","volume":"32","author":"BJ Casey","year":"2018","unstructured":"Casey BJ, Cannonier T, Conley MI, Cohen AO, Barch DM, Heitzeg MM. The Adolescent Brain Cognitive Development (ABCD) study: imaging acquisition across 21 sites. Dev Cogn Neurosci. 2018;32:43\u201354.","journal-title":"Dev Cogn Neurosci"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.schres.2023.02.018","volume":"254","author":"M Cecchi","year":"2023","unstructured":"Cecchi M, Adachi M, Basile A, Buhl DL, Chadchankar H, Christensen S. Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers. Schizophr Res. 2023;254:178\u201389.","journal-title":"Schizophr Res"},{"issue":"1","key":"3_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/schbul\/sbab090","volume":"48","author":"BA Clementz","year":"2022","unstructured":"Clementz BA, Parker DA, Trotti RL, McDowell JE, Keedy SK, Keshavan MS. Psychosis biotypes: replication and validation from the B-SNIP consortium. Schizophr Bull. 2022;48(1):56\u201368.","journal-title":"Schizophr Bull"},{"key":"3_CR11","unstructured":"ClinTrials. Antipsychotic response to Clozapine in B-SNIP Biotype-1 [Internet]. 2023. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04580134?term=clozapine&cond=Psychotic+Disorders&draw=2&rank=10."},{"key":"3_CR12","unstructured":"CORDIS. 2023. Available from: https:\/\/cordis.europa.eu\/project\/id\/115916."},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neubiorev.2018.09.004","volume":"97","author":"P Danjou","year":"2019","unstructured":"Danjou P, Viardot G, Maurice D, Garc\u00e9s PP, Wams EJ, Phillips KG. Electrophysiological assessment methodology of sensory processing dysfunction in schizophrenia and dementia of the Alzheimer type. Neurosci Biobehav Rev. 2019;97:70\u201384.","journal-title":"Neurosci Biobehav Rev"},{"key":"3_CR14","unstructured":"Deloitte. Public private partnership overview [Internet]. 2017. Available from: https:\/\/www2.deloitte.com\/content\/dam\/Deloitte\/us\/Documents\/life-sciences-health-care\/us-lshc-partnering-for-progress-how-collaborations-are-fueling-biomedical-advances-abridged-version.pdf."},{"key":"3_CR15","unstructured":"ERP Biomarker Qualification Consortium [Internet]. 2023. Available from: https:\/\/erpbiomarkers.org\/."},{"key":"3_CR16","unstructured":"EU-AIMS 2 [Internet]. 2023. Available from: https:\/\/www.aims-2-trials.eu\/our-research\/biomarkers\/."},{"issue":"3","key":"3_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0193-953X(18)30746-9","volume":"7","author":"I Extein","year":"1984","unstructured":"Extein I, Gold MS, Pottash AL. Psychopharmacologic treatment of depression. Psychiatr Clin North Am. 1984;7(3):503\u201317.","journal-title":"Psychiatr Clin North Am"},{"key":"3_CR18","first-page":"243","volume":"32","author":"J-E Faure","year":"2018","unstructured":"Faure J-E, Dyl\u0105g T, Norstedt I, Matthiessen L. The European Innovative Medicines Initiative: progress to date. Pharmaceut Med. 2018;32:243\u20139.","journal-title":"Pharmaceut Med"},{"key":"3_CR19","unstructured":"FDA. Scientific public private partnerships [Internet]. 2023. Available from: https:\/\/www.fda.gov\/drugs\/science-and-research-drugs\/scientific-public-private-partnerships-and-consortia\/."},{"key":"3_CR21","unstructured":"FNIH. Foundation of the National Institutes of Health Biomarkers Consortium [Internet]. 2023a. Available from: https:\/\/fnih.org\/our-programs\/biomarkers-consortium\/."},{"key":"3_CR22","unstructured":"FNIH. Biomarkers Consortium - Plasma A\u03b2 as a Predictor of Amyloid Positivity in Alzheimer\u2019s Disease- Transforming the ability to treat Alzheimer\u2019s disease by enabling early and reliable diagnosis [Internet]. 2023b. Available from: https:\/\/fnih.org\/our-programs\/biomarkers-consortium\/programs\/plasma-abeta."},{"key":"3_CR23","unstructured":"FNIH. Accelerating Medicines Partnership\u00ae Program\u2014Schizophrenia (AMP\u00ae SCZ), Pioneering the identification of early indicators of schizophrenia to catalyze better treatment development for patients [Internet]. 2023c. Available from: https:\/\/fnih.org\/our-programs\/AMP\/schizophrenia."},{"key":"3_CR24","unstructured":"FNIH. Accelerating Medicines Partnership\u00ae Program - Alzheimer\u2019s Disease Phase 1, Revolutionizing knowledge of Alzheimer\u2019s disease to develop better treatments [Internet]. 2023d. Available from: https:\/\/fnih.org\/our-programs\/AMP\/amp-ad\/1.0."},{"key":"3_CR25","unstructured":"FNIH. Accelerating Medicines Partnership\u00ae Program - Parkinson\u2019s Disease [Internet]. 2023e. Available from: https:\/\/amp-pd.org\/data\/summary-data-dashboard."},{"key":"3_CR26","unstructured":"FNIH. Accelerating Medicines Partnership\u00ae Program - Parkinson\u2019s Disease, Combining data and resources to develop novel treatments for Parkinson\u2019s disease [Internet]. 2023f. Available from: https:\/\/fnih.org\/our-programs\/amp\/accelerating-medicines-partnership-parkinsons."},{"key":"3_CR27","unstructured":"Fox M. Michael J Fox Foundation for Parkinson\u2019s Research [Internet]. 2023. Available from: https:\/\/www.michaeljfox.org\/."},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/psp4.12478","volume":"9","author":"H Geerts","year":"2020","unstructured":"Geerts H, Wikswo J, Graaf PH, Bai JPF, Gaiteri C, Bennett D, et al. Quantitative systems pharmacology for neuroscience drug discovery and development: current status, opportunities, and challenges. CPT Pharmacometrics Syst Pharmacol. 2020;9:5\u201320.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"3_CR29","unstructured":"GP2. Global Parkinson\u2019s Genetics Program [Internet]. 2023. Available from: https:\/\/gp2.org\/cohort-dashboard-advanced\/."},{"key":"3_CR30","unstructured":"HCP. Human Connectome Project [Internet]. 2023. Available from: https:\/\/www.humanconnectome.org."},{"key":"3_CR31","unstructured":"IMAGEN European IMAGEN Consortium [Internet]. 2023. Available from: https:\/\/www.imagen-europe.com."},{"key":"3_CR32","unstructured":"IMI. Innovative Medicines Initiative [Internet]. 2023a. Available from: http:\/\/www.imi.europa.eu."},{"key":"3_CR33","unstructured":"IMI. Innovative Medicine Initiative\u2014NEWMEDS Project [Internet]. 2023b. Available from: https:\/\/www.imi.europa.eu\/projects-results\/project-factsheets\/newmeds."},{"key":"3_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119046","volume":"252","author":"JT Kennedy","year":"2022","unstructured":"Kennedy JT, Harms MP, Korucuoglu O, Astafiev SV, Barch DM, Thompson WK. Reliability and stability challenges in ABCD task fMRI data. NeuroImage. 2022;252:119046.","journal-title":"NeuroImage"},{"issue":"12","key":"3_CR35","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/alz.12353","volume":"17","author":"O Libiger","year":"2021","unstructured":"Libiger O, Shaw LM, Watson MH, Nairn AC, Uma\u00f1a KL, Biarnes MC. Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer\u2019s disease. Alzheimers Dement. 2021;17(12):1976\u201387.","journal-title":"Alzheimers Dement"},{"key":"3_CR36","unstructured":"LONI Laboratory of Neuroimaging of the University of Southern California [Internet]. 2023. Available from: https:\/\/loni.usc.edu\/."},{"key":"3_CR37","unstructured":"NCATS Templates for Success: Speeding the Formation of Public-Private Partnerships [Internet]. 2023. Available from: https:\/\/ncats.nih.gov\/pubs\/features\/ntu-template."},{"key":"3_CR38","unstructured":"NIH Common Fund: Summary of Public Private Partnerships Opportunities [Internet]. 2023. Available from: https:\/\/ppp.od.nih.gov\/."},{"key":"3_CR39","unstructured":"NIMH Data Archive - EMBARC [Internet]. 2023a. Available from: https:\/\/nda.nih.gov\/edit_collection.html?id=2199."},{"key":"3_CR40","unstructured":"NIMH Data Archive. 2023b [Internet]. Available from: https:\/\/nda.nih.gov\/."},{"key":"3_CR41","doi-asserted-by":"publisher","first-page":"1174079","DOI":"10.3389\/fneur.2023.1174079","volume":"14","author":"H North","year":"2023","unstructured":"North H, Hofmann-Apitius M, Kas MJH, Marston H, Haas M. Models and methods: a perspective of the impact of six IMI translational data-centric initiatives for Alzheimer\u2019s disease and other neuropsychiatric disorders. Front Neurol. 2023;14:1174079.","journal-title":"Front Neurol"},{"key":"3_CR42","unstructured":"PING. Pediatric Imaging, Neurocognition, and Genetics Study [Internet]. 2023. Available from: http:\/\/pingstudy.ucsd.edu."},{"key":"3_CR43","unstructured":"PPMI. Parkinson\u2019s Progression Biomarkers Initiative [Internet]. 2023. Available from: https:\/\/www.ppmi-info.org\/."},{"key":"3_CR44","unstructured":"Psychiatric Ratings using Intermediate Stratified Markers 2 [Internet]. 2023. Available from: https:\/\/prism2-project.eu\/en\/prism-project\/objectives\/."},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jad.2022.01.105","volume":"302","author":"J Rabinowitz","year":"2022","unstructured":"Rabinowitz J, Williams JWB, Anderson A, Fu DJ, Hefting N, Kadriu B. Consistency checks to improve measurement with the Hamilton Rating Scale for Depression (HAM-D). J Affect Disord. 2022;302:273\u20139.","journal-title":"J Affect Disord"},{"issue":"4","key":"3_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamapsychiatry.2019.3867","volume":"77","author":"CE Rolle","year":"2020","unstructured":"Rolle CE, Fonzo GA, Wu W, Toll R, Jha MK, Cooper C. Cortical connectivity moderators of antidepressant vs placebo treatment response in major depressive disorder: secondary analysis of a randomized clinical trial. JAMA Psychiatry. 2020;77(4):397\u2013408.","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"3_CR47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/155005940603700205","volume":"37","author":"B Saletu","year":"2006","unstructured":"Saletu B, Anderer P, Saletu-Zyhlarz GM. EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs. Clin EEG Neurosci. 2006;37(2):66\u201380.","journal-title":"Clin EEG Neurosci"},{"key":"3_CR48","unstructured":"Schizophrenia Spectrum Biomarkers Consortium [Internet]. 2023. Available from: https:\/\/ssbcbio.org\/history_and_objectives.html."},{"issue":"3","key":"3_CR49","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jalz.2010.03.010","volume":"6","author":"ME Schmidt","year":"2010","unstructured":"Schmidt ME, Siemers E, Snyder PJ, Potter WZ, Cole P, Soares H. The Alzheimer\u2019s disease neuroimaging initiative: perspectives of the Industry Scientific Advisory Board. Alzheimers Dement. 2010;6(3):286\u201390.","journal-title":"Alzheimers Dement"},{"key":"3_CR50","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1056\/NEJMc1908881","volume":"381","author":"CG Schwarz","year":"2019","unstructured":"Schwarz CG, Kremers WK, Therneau TM, Sharp RR, Gunter JL, Vemuri P. Identification of anonymous MRI research participants with face-recognition software. N Engl J Med. 2019;381:1684\u20136.","journal-title":"N Engl J Med"},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"117845","DOI":"10.1016\/j.neuroimage.2021.117845","volume":"231","author":"CG Schwarz","year":"2021","unstructured":"Schwarz CG, Kremers WK, Wiste HJ, Gunter JL, Vemuri P, Spychalla AJ. Changing the face of neuroimaging research: comparing a new MRI de-facing technique with popular alternatives. NeuroImage. 2021;231:117845.","journal-title":"NeuroImage"},{"issue":"5","key":"3_CR52","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1176\/appi.ajp.2020.20030280","volume":"177","author":"T Spellman","year":"2020","unstructured":"Spellman T, Liston C. Toward circuit mechanisms of pathophysiology in depression. Am J Psychiatry. 2020;177(5):381\u201390.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"3_CR53","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/alz.12422","volume":"18","author":"DP Veitch","year":"2022","unstructured":"Veitch DP, Weiner MW, Aisen PS, Beckett LA, DeCarli C, Green R. Using the Alzheimer\u2019s disease neuroimaging initiative to improve early detection, diagnosis, and treatment of Alzheimer\u2019s disease. Alzheimers Dement. 2022;18(4):824\u201357.","journal-title":"Alzheimers Dement"},{"key":"3_CR55","volume-title":"Genomic and personalized medicine","author":"DN Wholley","year":"2013","unstructured":"Wholley DN. Public\u2013private partnerships in biomarker research. In: Ginsburg, Willard, editors. Genomic and personalized medicine. 2nd ed; 2013.","edition":"2"}],"container-title":["Advances in Neurobiology","Neurophysiologic Biomarkers in Neuropsychiatric Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-69491-2_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T19:03:32Z","timestamp":1732043012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-69491-2_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031694905","9783031694912"],"references-count":53,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-69491-2_3","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"type":"print","value":"2190-5215"},{"type":"electronic","value":"2190-5223"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"20 November 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}